BCAX in the 13F filings
Bicara Therapeutics Inc · CUSIP 055477103
- Quarter end
- 31 Mar 2026
- the date the book describes
- Filed
- 18 May 2026
- latest of these filings; the earliest 12 May 2026
- Managers listing it
- 16
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q4 2025 and Q1 2026; 1 listed it in both
- Shares listed
- 9,693,792
- combined, among listed positions
- Reported value
- $193m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 10 buyers (opened or added shares) and 8 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +108,199.
Managers listing BCAX in Q1 2026
16 of 16 holders
Largest increases and reductions, by shares
Increases
- Citadel Advisors LLCexisting position · 1,659,342 shares now+887,084
- Janus Henderson Group Ltdexisting position · 3,339,218 shares now+692,933
- D. E. Shaw & Co.existing position · 276,943 shares now+140,421
- Walleye Capital LLCnew position · 108,008 shares now+108,008
- Hudson Bay Capital Management LPexisting position · 233,703 shares now+83,703
Reductions
- Fidelity (FMR LLC)existing position · 2,100,929 shares now-1,246,294
- Millennium Management LLCexisting position · 156,702 shares now-277,997
- T. Rowe Price Associates Incexisting position · 1,376,198 shares now-183,337
- Susquehanna International Group LLPexisting position · 10,944 shares now-19,749
- Two Sigma Investments LPexisting position · 89,881 shares now-8,600
New positions and exits
New (4)
Exited (3)
- Jane Street Group LLCwas $1.4m
- Tudor Investment Corpwas $461k
- Brevan Howard Capital Management LPwas $238k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q3 2024 | 4 | $38m | 4 | 0 |
| Q4 2024 | 1 | $4.8m | 0 | 3 |
| Q2 2025 | 1 | $3.7m | 1 | 0 |
| Q3 2025 | 1 | $8.0m | 1 | 1 |
| Q4 2025 | 1 | $44m | 11 | 8 |
| Q1 2026 | 1 | $66m | 10 | 8 |
| Q2 2026 | 2 | $104m | 7 | 8 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
BCAX and LLY →BCAX and TMO →BCAX and JNJ →Choose a stock to compare with BCAX →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own BCAX, latest filings →Back to the 13F Explorer →